bioAffinity Technologies
BIAF
4 hedge funds and large institutions have $134K invested in bioAffinity Technologies in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.05% → 0.03% (-0.02%)
20% less funds holding
Funds holding: 5 → 4 (-1)
30% less capital invested
Capital invested by funds: $192K → $134K (-$58.5K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Financial Engines Advisors
Santa Clara,
California
|
+$164K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.18K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$76 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$60K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$44.2K |
| 3 |
Jane Street
New York
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Financial Engines Advisors
Santa Clara,
California
| $104K | +$164K | +2,158 | New |
|
|
2
Creative Planning
Overland Park,
Kansas
| $19.4K | -$44.2K | -582 | -59% |
|
|
3
UBS Group
Zurich,
Switzerland
| $10.5K | +$4.18K | +55 | +34% |
|
|
4
Wells Fargo
San Francisco,
California
| $43 | +$76 | +1 | New |
|
5
Morgan Stanley
New York
| $5 | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$60K | -686 | Closed |
|
|
7
Jane Street
New York
| – | -$32K | -367 | Closed |
|
BIAF Hedge Fund Activity: Q4 2022 in Review
4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q4 2022, worth a combined $134K — down 30% from $192K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BIAF and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Financial Engines Advisors, opening a new position worth an estimated $164K. The largest seller was Citadel Advisors, exiting entirely with an estimated $60K sold.
- 4 institutional investors held bioAffinity Technologies (BIAF) as of Q4 2022, down from 5 in Q3 2022.
- Funds reported $134K of bioAffinity Technologies stock for Q4 2022, down 30% quarter-over-quarter.
- 2 funds opened new bioAffinity Technologies positions in Q4 2022 and 3 closed out, a net change of -1 holder.
- The largest bioAffinity Technologies buyer in Q4 2022 was Financial Engines Advisors, an estimated $164K added.
- The largest bioAffinity Technologies seller in Q4 2022 was Citadel Advisors, an estimated $60K sold.
Based on aggregated 13F filings for Q4 2022.